Back

No improvement in atrial arrhythmia rates in patients on baroreflex activation therapy

30 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Interactions between atrial fibrillation and heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Vu Pham

Lac and USC Medical Centre, Los Angeles (United States of America)

6 More presentations in this session

Presentation thumbnail
Assessing stroke and mortality risk in heart failure: the CHA2DS2-VASc score's prognostic value in patients with and without atrial fibrillation - a systematic review and meta analysis
Doctor I. Kamel (Boston, US)
Abstract Slides Video
Presentation thumbnail
Proteomic biomarkers and biological mechanisms associated with atrial fibrillation in heart failure patients
Mr T. Petersen (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
The efficacy of catheter ablation compared to medical therapy in heart failure patients with concomitant atrial fibrillation: A meta-analysis of randomized controlled trials
Doctor M. Ishrak Khan (New York City, US)
Abstract Slides Video
Presentation thumbnail
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction
Mr O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Presence of Atrial Fibrillation (AF) is a poor prognostic marker in patients with Heart Failure with reduced Ejection Fraction (HFrEF) and Left Bundle Branch Block (LBBB)
Doctor S. Deshpande (Pune, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Interactions between atrial fibrillation and heart failure

The Event

Event poster

ESC Congress 2024

30 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Outpatient diuretic use in patients with baroreflex activation therapy
thumbnail
Congress Presentation
BeAT-HF: long-term safety profile and outcomes
thumbnail
Congress Session
Baroreflex activation therapy for HFrEF patients: long-term data and real-world experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources